<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-DOD-17012573</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2017-09-05</date_registration>
      <primary_sponsor>First Affilited Hospital of Guangxi Medical University</primary_sponsor>
      <public_title>Influence of Pretransplantation Myocardial and liver MRI in beta-thalassemia major undergoing Allogeneic Hematopoietic Stem Cell</public_title>
      <acronym />
      <scientific_title>Influence of Pretransplantation Myocardial and liver MRI in beta-thalassemia major undergoing Allogeneic Hematopoietic Stem Cell</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-09-01</date_enrolment>
      <type_enrolment />
      <target_size>Target condition:60;Difficult condition:0</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=21430</url>
      <study_type>Diagnostic test</study_type>
      <study_design>Diagnostic test for accuracy</study_design>
      <phase>Other</phase>
      <hc_freetext> beta-thalassemia major</hc_freetext>
      <i_freetext>Gold Standard:A normal MRI T2* liver is &gt;6.3 ms. Mild liver iron overload was defined by MRI T2* between 2.7 ms and 6.3 ms. Moderate liver iron overload was defined by MRI T2* between 1.4 ms and 2.7 ms. Severe liver iron overload was defined by MRI T2* &lt;1.4 ms. A normal MRI T2* heart is &gt;20&#x3;;Index test:Nuclear&amp;#32;Magnetic&amp;#32;Resonance;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Yunyan He</firstname>
        <middlename />
        <lastname />
        <address>6 Shuangyong Road, Qingxiu District, Nanning, Guangxi Zhuang Autonomous Region, China</address>
        <city />
        <country1 />
        <zip>530021</zip>
        <telephone>+86 13607868275</telephone>
        <email>yunyanhe@aliyun.com</email>
        <affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangxi medical university</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Jianming Luo</firstname>
        <middlename />
        <lastname />
        <address>6 Shuangyong Road, Qingxiu District, Nanning, Guangxi Zhuang Autonomous Region, China</address>
        <city />
        <country1 />
        <zip>530021</zip>
        <telephone>+86 13517667021</telephone>
        <email>jmluo@aliyun.com</email>
        <affiliation>Department of Pediatrics, The First Affiliated Hospital of Guangxi medical university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients are diagnosed β-thalassaemia major and will proceed allogeneic hematopoietic stem cell transplantation. All cases are in line with HLA matching high-resolution 10／10 matched, age from 2 to14 years old. Gender is not limited to a male/female.</inclusion_criteria>
      <agemin>2</agemin>
      <agemax>14</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. Patients with unstable vital sign or by other physiological or mental reasons can not undergo MRI exam;
2. Relatives of the patient refuse to join this research;
3. Patients with other diseases which can lead to iron overload;
4. Patients with other diseases in liver or heart(ie. neoplasms);
5. patients have inflamation, liver disease, heart failure or arrhythmia.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code />
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>serum ferritin (SF);iron level of liver;iron level of Myocardium;ejection fraction;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome />
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>self-financing</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-08-25</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>